Skip to main content
Erschienen in: International Urology and Nephrology 2/2012

01.04.2012 | Nephrology – Original Paper

The spectrum of renal abnormalities in patients with psoriasis

verfasst von: Erkan Dervisoglu, Aysun Sikar Akturk, Kursat Yildiz, Rebiay Kiran, Ahmet Yilmaz

Erschienen in: International Urology and Nephrology | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

Kidney involvement secondary to psoriasis is a controversial issue. In this study, we evaluated the prevalence of urinary abnormalities in patients with psoriasis.

Materials and methods

Forty-five psoriasis patients (28 women, 17 men, mean age 44 ± 14 years) and 45 age- and gender-matched control subjects without hypertension or diabetes were enrolled in the study. Psoriasis area and severity index (PASI) was used to assess the severity of psoriasis. Urinalysis by dipstick and microscopic evaluation and 24-h proteinuria and albuminuria were measured in all patients and controls. Pathologic albuminuria was defined as albumin excretion of more than 30 mg/24 h. Renal biopsy was performed in psoriasis patients with urinary abnormalities.

Results

Patients with psoriasis and controls were not significantly different with respect to the prevalence of abnormal urinalysis (17.7% vs. 13.3%, P = 0.56), mean 24-h proteinuria (145 ± 66 mg/24 h vs. 141 ± 71 mg/24 h, P = 0.54), and albuminuria (21 ± 34 mg/24 h vs. 8 ± 9 mg/24 h, P = 0.31). However, patients with psoriasis had an increased prevalence of pathologic albuminuria compared with controls (24% vs. 2%, P = 0.005). PASI scores in psoriasis patients correlated significantly with 24-h albuminuria (r = 0.458, P = 0.007). Of the eight patients with psoriasis who had urinary abnormalities, four underwent renal biopsy. Two of them had biopsy-proven glomerulonephritis: mesangial proliferative glomerulonephritis in one and IgA nephropathy in the other.

Conclusion

The presence of abnormal urinalysis was not more common in patients with psoriasis than in controls. However, the increased prevalence of pathologic albuminuria and its positive correlation with psoriasis severity may suggest subclinical glomerular dysfunction in these patients.
Literatur
1.
Zurück zum Zitat Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866–873PubMedCrossRef Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866–873PubMedCrossRef
3.
Zurück zum Zitat Griffiths CE, Voorhees JJ (1996) Psoriasis, T cells and autoimmunity. J R Soc Med 89:315–319PubMed Griffiths CE, Voorhees JJ (1996) Psoriasis, T cells and autoimmunity. J R Soc Med 89:315–319PubMed
4.
Zurück zum Zitat Heuvels J, Maximus A, Bosmans JL et al (1999) Renal abnormalities in psoriatic patients: a review. Nephron 82:1–6PubMedCrossRef Heuvels J, Maximus A, Bosmans JL et al (1999) Renal abnormalities in psoriatic patients: a review. Nephron 82:1–6PubMedCrossRef
5.
Zurück zum Zitat Szepietowski JC, Szepietowski T (2000) Is renal function altered in patients with psoriasis vulgaris?–A short review. J Dermatol 27:569–572PubMed Szepietowski JC, Szepietowski T (2000) Is renal function altered in patients with psoriasis vulgaris?–A short review. J Dermatol 27:569–572PubMed
6.
Zurück zum Zitat Ahuja TS, Funtanilla M, de Groot JJ et al (1998) IgA nephropathy in psoriasis. Am J Nephrol 18:425–429PubMedCrossRef Ahuja TS, Funtanilla M, de Groot JJ et al (1998) IgA nephropathy in psoriasis. Am J Nephrol 18:425–429PubMedCrossRef
7.
Zurück zum Zitat Alenius GM, Stegmayr BG, Dahlqvist SR (2001) Renal abnormalities in a population of patients with psoriatic arthritis. Scand J Rheumatol 30:271–274PubMedCrossRef Alenius GM, Stegmayr BG, Dahlqvist SR (2001) Renal abnormalities in a population of patients with psoriatic arthritis. Scand J Rheumatol 30:271–274PubMedCrossRef
8.
Zurück zum Zitat Singh NP, Prakash A, Kubba S et al (2005) Psoriatic nephropathy–does an entity exist? Ren Fail 27:123–127PubMed Singh NP, Prakash A, Kubba S et al (2005) Psoriatic nephropathy–does an entity exist? Ren Fail 27:123–127PubMed
9.
Zurück zum Zitat Akoglu H, Dede F, Akoglu G et al (2009) Membranoproliferative glomerulonephritis associated with psoriasis vulgaris. Ren Fail 31:858–861PubMedCrossRef Akoglu H, Dede F, Akoglu G et al (2009) Membranoproliferative glomerulonephritis associated with psoriasis vulgaris. Ren Fail 31:858–861PubMedCrossRef
10.
Zurück zum Zitat Chapman JR (2011) Chronic calcineurin inhibitor nephrotoxicity-lest we forget. Am J Transplant 11:693–697PubMedCrossRef Chapman JR (2011) Chronic calcineurin inhibitor nephrotoxicity-lest we forget. Am J Transplant 11:693–697PubMedCrossRef
11.
Zurück zum Zitat Widemann BC, Adamson PC (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist 11:694–703PubMedCrossRef Widemann BC, Adamson PC (2006) Understanding and managing methotrexate nephrotoxicity. Oncologist 11:694–703PubMedCrossRef
12.
Zurück zum Zitat Madeddu P, Ena P, Glorioso N et al (1988) High prevalence of microproteinuria, an early index of renal impairment, in patients with diffuse psoriasis. Nephron 48:222–225PubMedCrossRef Madeddu P, Ena P, Glorioso N et al (1988) High prevalence of microproteinuria, an early index of renal impairment, in patients with diffuse psoriasis. Nephron 48:222–225PubMedCrossRef
13.
Zurück zum Zitat Cecchi R, Seghieri G, Gironi A et al (1992) Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology 185:93–95PubMedCrossRef Cecchi R, Seghieri G, Gironi A et al (1992) Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology 185:93–95PubMedCrossRef
14.
Zurück zum Zitat Szepietowski JC, Bielicka E, Wasik F et al (2000) Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris. J Eur Acad Dermatol Venereol 14:513–514PubMedCrossRef Szepietowski JC, Bielicka E, Wasik F et al (2000) Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris. J Eur Acad Dermatol Venereol 14:513–514PubMedCrossRef
15.
Zurück zum Zitat Jacobson CC, Kimball AB (2004) Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased. Br J Dermatol 151:381–387PubMedCrossRef Jacobson CC, Kimball AB (2004) Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased. Br J Dermatol 151:381–387PubMedCrossRef
16.
Zurück zum Zitat Doolan PD, Alpen EL, Theil GB (1962) A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 32:65–79PubMedCrossRef Doolan PD, Alpen EL, Theil GB (1962) A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med 32:65–79PubMedCrossRef
17.
Zurück zum Zitat Bossini N, Savoldi S, Franceschini F et al (2001) Clinical and morphological features of kidney involvement in primary Sjögren’s syndrome. Nephrol Dial Transplant 16:2328–2336PubMedCrossRef Bossini N, Savoldi S, Franceschini F et al (2001) Clinical and morphological features of kidney involvement in primary Sjögren’s syndrome. Nephrol Dial Transplant 16:2328–2336PubMedCrossRef
18.
Zurück zum Zitat Jayne D (2009) Hematuria and proteinuria. In: Greenberg A (ed) Primer on kidney diseases. Saunders Elsevier, Philadelphia, pp 33–42 Jayne D (2009) Hematuria and proteinuria. In: Greenberg A (ed) Primer on kidney diseases. Saunders Elsevier, Philadelphia, pp 33–42
19.
Zurück zum Zitat Viberti GC, Hill RD, Jarrett RJ et al (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430–1432PubMedCrossRef Viberti GC, Hill RD, Jarrett RJ et al (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430–1432PubMedCrossRef
20.
Zurück zum Zitat Erley CM, Risler T (1994) Microalbuminuria in primary hypertension: is it a marker of glomerular damage? Nephrol Dial Transplant 9:1713–1715PubMed Erley CM, Risler T (1994) Microalbuminuria in primary hypertension: is it a marker of glomerular damage? Nephrol Dial Transplant 9:1713–1715PubMed
21.
Zurück zum Zitat Kaftan O, Kaftan B, Toppare MF et al (1996) Renal involvement in psoriasis. Dermatology 192:189–190PubMedCrossRef Kaftan O, Kaftan B, Toppare MF et al (1996) Renal involvement in psoriasis. Dermatology 192:189–190PubMedCrossRef
22.
Zurück zum Zitat Zadrazil J, Tichy T, Horak P et al (2006) IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of ‘psoriatic nephropathy’. J Nephrol 19:382–386PubMed Zadrazil J, Tichy T, Horak P et al (2006) IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of ‘psoriatic nephropathy’. J Nephrol 19:382–386PubMed
23.
Zurück zum Zitat Jiao Y, Xu H, Li H et al (2008) Mesangial proliferatative glomerulonephritis with or without IgA deposits: the morphological characters in psoriasis vulgaris. Nephron Clin Pract 108:221–225CrossRef Jiao Y, Xu H, Li H et al (2008) Mesangial proliferatative glomerulonephritis with or without IgA deposits: the morphological characters in psoriasis vulgaris. Nephron Clin Pract 108:221–225CrossRef
24.
Zurück zum Zitat Kim M, Ko Y, Yeo UC et al (1998) Psoriasis and glomerulonephritis. Clin Exp Dermatol 23:295–296PubMedCrossRef Kim M, Ko Y, Yeo UC et al (1998) Psoriasis and glomerulonephritis. Clin Exp Dermatol 23:295–296PubMedCrossRef
25.
Zurück zum Zitat [No authors listed] (2002) National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39:1–266 [No authors listed] (2002) National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39:1–266
Metadaten
Titel
The spectrum of renal abnormalities in patients with psoriasis
verfasst von
Erkan Dervisoglu
Aysun Sikar Akturk
Kursat Yildiz
Rebiay Kiran
Ahmet Yilmaz
Publikationsdatum
01.04.2012
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2012
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-9966-1

Weitere Artikel der Ausgabe 2/2012

International Urology and Nephrology 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.